xinca suspensionskoncentrat
nufarm deutschland gmbh - bromoxynil - suspensionskoncentrat - 401,6 g/l bromoxynil
folicur ew 250 olie i vand emulsion
bayer a/s - tebuconazol - olie i vand emulsion - 250 g/l tebuconazol
folicur xpert emulsionskoncentrat
bayer a/s - tebuconazol, prothioconazol - emulsionskoncentrat - 160 g/l tebuconazol ; 80 g/l prothioconazol
proline xpert emulsionskoncentrat
bayer a/s - tebuconazol, prothioconazol - emulsionskoncentrat - 80 g/l tebuconazol ; 160 g/l prothioconazol
prosaro ec 250 emulsionskoncentrat
bayer a/s - tebuconazol, prothioconazol - emulsionskoncentrat - 125 g/l tebuconazol ; 125 g/l prothioconazol
scala suspensionskoncentrat
basf a/s - pyrimethanil - suspensionskoncentrat - 400 g/l pyrimethanil
pro-tector suspoemulsion
vestjydsk agro - prothioconazol, fluopyram - suspoemulsion - 125 g/l prothioconazol ; 125 g/l fluopyram
mirror suspensionskoncentrat
adama northern europe b.v. - folpet - suspensionskoncentrat - 500 g/l folpet
deltyba
otsuka novel products gmbh - delamanid - tuberkulose, multidrugt-resistent - antimyco-bakterielle midler - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
toviaz
pfizer europe ma eeig - fesoterodinfumarat - urinblære, overaktiv - urologicals - behandling af symptomer (øget frekvens og / eller hastende karakter og / eller hastende karakter urininkontinens) der kan forekomme hos patienter med overaktiv blære syndrom.